EDESA BIOTECH, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
EDESA BIOTECH, INC. (EDSA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 4.43 thousand shares for the 9-month period ending 2025-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-08-13
- EDESA BIOTECH, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2024-09-30 was -2.21K shares.
- EDESA BIOTECH, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2024-06-30 was 1.07K shares.
- EDESA BIOTECH, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2023-09-30 was -10.38K shares.
- EDESA BIOTECH, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 196.00 shares, a 91.84% decline from fiscal 2023.
- EDESA BIOTECH, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 2.40K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month as first filed |
|---|---|---|---|---|---|
| 2025-06-30 | 4.43K shares 10-Q · filed 2026-08-13 | ||||
| 2024-09-30 | -2.21K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-12 | -1.14K shares derived: sum of 2 quarters · filed 2025-12-12 | 196.00 shares 10-K · filed 2025-12-12 | 2.40K shares 10-K · filed 2024-12-13 | |
| 2024-06-30 | 1.07K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-08 | 2.40K shares 10-Q · filed 2025-08-08 | |||
| 2024-03-31 | 1.33K shares 10-Q · filed 2025-05-14 | ||||
| 2023-09-30 | -10.38K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-12 | 2.40K shares 10-K · filed 2025-12-12 | 12.78K shares 10-K · filed 2024-12-13 | ||
| 2023-06-30 | 12.78K shares 10-Q · filed 2024-08-09 | ||||
| 2021-03-31 | 19.07K shares 10-Q · filed 2021-05-14 | ||||
| 2020-09-30 | 5.79K shares 10-Q · filed 2021-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |